For those of you following along, the BME Research+Design Symposium Site has been recently updated with more information about the upcoming event. We are expecting a capacity crowd again this year that the NC Biotechnology Center.
Don't miss out on this great networking opportunity and chance to see undergraduate and graduate students present research and innovations. Projects range from a device to prevent skin degradation in neonates to a targeted drug delivery system for treatment of ischemic stroke.
Register today for the event, May 3rd, NCBC, from 3:00 - 8:00
www.bme.ncsu.edu/symposium/
Thank you to the generous sponsors that helped make this event possible, including WakeMed, the NC Biotechnology Center, Hutchison Law Group, Applied Technologies, Polyzen, Olive Law Group, Flexcell, Smith Anderson, and Jenkins Wilson Taylor & Hunt. A special thank you to the Reception Sponsor, Cook Medical.
Thursday, April 14, 2011
Subscribe to:
Posts (Atom)
Live Feeds Disclaimer
The live feeds below are provided direct from the source, including public and private sector sources such as the FDA, Medical Product Manufacturing News, BioSpace, and Twitter Feeds.
The information provided from these feeds are not filtered for content by this blog, nor are they considered the opinion of this blog.
The information provided from these feeds are not filtered for content by this blog, nor are they considered the opinion of this blog.
MedCity News » North Carolina
- First-in-Class Brain Cancer Drug Strikes a Chord With Jazz Pharma to the Tune of a $935M M&A Deal
- How UNC Health Saved Over $5M On Annual Nurse Turnover Costs
- How Genome Sequencing Can Broaden the Scope of Newborn Screening
- While Auto vs. Allo Cell Therapy Debate Continues, VCs Look for ‘Next Shiny Thing’
- Precision Bio Offloads Lead Cell Therapy Program in Pivot to In Vivo Gene Editing
FDA's Center for Devices and Radiological Health
Error loading feed.
Medical Product Manufacturing News
Error loading feed.
BioSpace.com Featured News and Stories
- Ablynx Drug Fails Again in Mid-Stage Trial
- Allecra Therapeutics New Antibiotic Shows Promise for Resistant Bacterial Infections
- ImmunoGen Stock Climbs on Positive Ovarian Cancer Data
- Stock Plunges Despite Biohaven's Positive Migraine Data
- Protagonist Craters After Discontinuing Phase IIb Ulcerative Colitis Study
BioSpace.com Career News
- ImmunoGen Stock Climbs on Positive Ovarian Cancer Data
- Stock Plunges Despite Biohaven's Positive Migraine Data
- Protagonist Craters After Discontinuing Phase IIb Ulcerative Colitis Study
- Ablynx Drug Fails Again in Mid-Stage Trial
- Allecra Therapeutics New Antibiotic Shows Promise for Resistant Bacterial Infections
NC Medical - Twitter Search
Error loading feed.
Biomedical Engineering - Twitter Search
Error loading feed.
Medical Device - Twitter Search
Error loading feed.
Pharmaceutical - Twitter Search
Error loading feed.
Biologics - Twitter Search
Error loading feed.
FDA Drug Info - Twitter Feed
Error loading feed.
FDA Recalls - Twitter Feed
Error loading feed.
FDA Women's Health - Twitter Feed
Error loading feed.
FasterCures Twitter Feed
Error loading feed.